This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mark, A. L. Articles by Sivitz, W. I. Search for Related Content PubMed PubMed Citation Articles by Mark, A. L. Articles by Sivitz, W. I.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:881.)
© 2002 American Heart Association, Inc.

Editorials

Uncoupling Metabolism and Coupling Leptin to Cardiovascular Disease

Allyn L. Mark; William I. Sivitz

From the Hypertension Genetics Specialized Center of Research, Cardiovascular Center, Diabetes and Endocrinology Research Center, and Department of Internal Medicine, University of Iowa; Roy J. and Lucille A. Carver College of Medicine; and Veterans Administration Medical Center, Iowa City.

Correspondence to Allyn L. Mark, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 218 CMAB, Iowa City, IA 52242-1101. E-mail allyn-mark@uiowa.edu

In the past eight years, beginning with the discovery of leptin, ¹ there has been an avalanche of knowledge and a conceptual revolution in understanding the regulation of body fat. Central to this revolution has been the recognition that adipose tissue is a tremendously active and important endocrine and paracrine tissue. In this regard, adipose tissue is to the last decade what the endothelium was to the previous decade—a large tissue previously relatively ignored that was found with a single discovery to be of great interest and importance.

See page 961

The interest in leptin focused initially on appetite, metabolism, and adiposity, but there is mounting evidence that leptin participates in sympathetic and arterial pressure regulation and in vascular biology.

Leptin increases sympathetic nerve activity² to thermogenic brown adipose tissue through a central neural action. This is not surprising, but leptin also increases sympathetic activity to the kidney and extremities.² This sympathoexcitatory action would be expected to increase arterial pressure.

Of perhaps greater interest to the readers of this Journal is the mounting evidence that the arterial wall is a target of leptin action. The signaling form of the leptin receptor was initially said to be expressed only in the hypothalamus, but we now know that it is also expressed in peripheral tissues.

For example, the long, signaling form of the leptin receptor is expressed in endothelial cells.^3,4 Lembo et al³ and Vecchione et al⁵ reported that leptin stimulates increases in endothelial NO synthesis.

Leptin promotes accumulation of reactive oxygen species . . . [Full Text of this Article]

This article has been cited by other articles:

				F Dong, X Zhang, X Yang, L B Esberg, H Yang, Z Zhang, B Culver, and J Ren Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice J. Endocrinol., January 1, 2006; 188(1): 25 - 36. [Abstract] [Full Text] [PDF]

				S. Konstantinides, K. Schafer, J. G. Neels, C. Dellas, and D. J. Loskutoff Inhibition of Endogenous Leptin Protects Mice From Arterial and Venous Thrombosis Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2196 - 2201. [Abstract] [Full Text] [PDF]

				M. Halle and P. B. Persson Role of leptin and leptin receptor in inflammation Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R760 - R762. [Full Text] [PDF]